Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nazimuddin Aboo
Observed name:
N. Aboo
Institution:
University of KwaZulu-Natal
Observed institutions:
Addington Hospital,
University of KwaZulu-Natal
OpenAlex ID:
A5111575217
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
2014
·
William J. Sandborn
, Subrata Ghosh
, et al.
·
Clinical Gastroenterology and Hepatology
·
321
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
2021
·
Silvio Danese
, Jean-Frederic Colombel
, et al.
·
The Lancet. Gastroenterology & hepatology
·
105
PDF
Acute Renal Failure in the “Comrades Marathon” Runners
1989
·
Y. K. Seedat
, N. Aboo
, et al.
·
Renal Failure
·
51
HLA class I and II antigens in South African Blacks with Graves' disease
1990
·
Mahomed A.K. Omar
, Michael G. Hammond
, et al.
·
Clinical Immunology and Immunopathology
·
31
Bezlotoxumab for Clostridium difficile Infection Complicating Inflammatory Bowel Disease
2018
·
Ciarán P. Kelly
, Mark H. Wilcox
, et al.
·
Gastroenterology
·
22
PDF
Esomeprazole 40 mg Administered Intravenously Has Similar Safety and Efficacy Profiles to the Oral Formulation in Patients with Erosive Esophagitis
2004
·
Herbert Schneider
, Christoffel van Rensburg
, et al.
·
Digestion
·
14
Characteristics and Outcomes in Patients with C. Difficile Infection (CDI) and Inflammatory Bowel Disease: Bezlotoxumab Versus Placebo
2017
·
Ciaran P. Kelly
, Mark Wilcox
, et al.
·
Gastroenterology
·
3
Acknowledgement to Referees
2004
·
O. Kelber
, M. Storr
, et al.
·
Digestion
PDF
Show more works
View as search
Works count:
8
Citation count:
547
H-index:
6
I10-index:
6
Year
Topic
Type